Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Operating Margin Over TimeContracting
Percentile Rank17
Studio
Year-over-Year Change

Operating income as a percentage of revenue

Percentile
P17
Within normal range
vs 5Y Ago
-1.4x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025-20.04%-95.8%
2024-10.24%+29.0%
2023-14.43%-1211.8%
2022-1.10%-115.4%
20217.16%-51.4%
202014.71%+149.4%
2019-29.81%-